Chronic diseases with a lifestyle-based aetiology currently make up a significant proportion of primary care consultations, but management often falls between the demands of public and clinical health.
A modified clinical approach, based around the concept of “lifestyle medicine”, helps fill the gap by adding behavioural, motivational and environmental skills to conventional medical practice.
When used in a multidisciplinary setting, lifestyle medicine offers potential cost and effectiveness benefits, which are beginning to be realised.
- 1. Australian Institute of Health and Welfare. Chronic diseases and associated risk factors in Australia, 2006. Canberra: AIHW, 2006. (AIHW Cat. No. PHE 81.)
- 2. Australia 2020 Summit: long-term health strategy. http://www.australia2020.gov.au/topics/docs/health.pdf (accessed Nov 2008).
- 3. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.
- 4. Egger G, Binns A, Rossner S. Lifestyle medicine. Sydney: McGraw-Hill Australia, 2008.
- 5. Rippe J, editor. Lifestyle medicine. New York: Blackwell, 1999.
- 6. Australian Government Department of Health and Ageing. Enhanced Primary Care Program (EPC). http://www.health.gov.au/epc (accessed Nov 2008).
- 7. Beilby JJ. Primary care reform using a layered approach to the Medicare Benefits Scheme: unpredictable and unmeasured. Med J Aust 2007; 187: 69-71. <MJA full text>
- 8. Egger G. Personal carbon trading: a potential “stealth intervention” for obesity reduction? Med J Aust 2007; 187: 185-187. <MJA full text>
- 9. Herder C, Peltonen M, Koenig W, et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes 2006; 55: 2340-2346.
- 10. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371: 1783-1789.
- 11. Haffner S, Temprosa M, Crandall J, et al; Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005; 54: 1566-1572.
- 12. Galani C, Schneider H, Rutten FF. Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland. Int J Public Health 2007; 52: 372-382.
- 13. Miller WR, Rollnick S. Motivational interviewing: preparing people for change. London: Guilford Press, 2002.
- 14. Barbour KA, Edenfield TM, Blumenthal JA. Exercise as a treatment for depression and other psychiatric disorders: a review. J Cardiopulm Rehabil Prev 2007; 27: 359-367.
- 15. Hotamisligil GS. Inflammation and metabolic disease. Nature 2006; 444: 860-867.
- 16. Sinzinger H, O’Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Brit J Clin Pharmacol 2004; 57: 525-528.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.